clofibrate has been researched along with Hepatic Encephalopathy in 1 studies
angiokapsul: contains clofibrate & insoitolnicotinate
Hepatic Encephalopathy: A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION (frequently progressing to COMA); ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes (see REFLEX, BABINSKI). ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. (From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum & Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cortesse, A | 1 |
| Franco, D | 1 |
| Beaubernard, C | 1 |
| Miramand, JL | 1 |
| Salomon, F | 1 |
| Gigou, M | 1 |
| Bismuth, H | 1 |
1 other study available for clofibrate and Hepatic Encephalopathy
| Article | Year |
|---|---|
Prevention of hepatic encephalopathy by clofibrate in the rat with portacaval anastomosis.
Topics: Animals; Clofibrate; Cytochromes; Hepatic Encephalopathy; Liver; Male; Organ Size; Portacaval Shunt, | 1980 |